Crossmark

Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy

Published Online: 2024-05-22

Published Print: 2024-10

Authors

Mahmoud, Lamiaa Mohamed

Mageed, Aya Aly Ashraf Abdel

Saadallah, Jackline Moawad

Youssef, Mira Farouk

Rashed, Liala Ahmed

Ammar, Hania Ibrahim
Funding

Funding for this research was provided by:

Cairo University
License Information

Text and Data Mining valid from 2024-05-22

Version of Record valid from 2024-05-22
More Information

Article History

Received: 19 April 2024

Accepted: 6 May 2024

First Online: 22 May 2024

Declarations

:

: The Institutional Animal Care and Use Committee of Cairo University approved the current research in accordance with ARRIVE guidelines and EU Directive 2010/63/EU guidelines for animals. The approval number is ID: CU III F 28 20.

: The authors declare no competing interests.

Document is current